Although KLF16 is known for its roles in glioblastoma and colorectal carcinomas, its specific function in glycolipid metabolism remains poorly understood, although it has been noted to mitigate fatty liver inflammation by targeting PPARα [12]. The gene discussed is KLF16; the disease is colorectal carcinoma.